Parkinson's Disease

With the advent of major organizations like the Michael J. Fox Foundation, Parkinson's research has never been busier. Current trials have focused on new symptomatic therapies and new methods of early diagnosis.

Condition(s) Type of Drug Phase Add-On Comparator Duration Open Label Extension
Mild to Moderate Parkinson's Disease Delayed Release Carbidopa/Levodopa III No 50% get plain CD/LD 24 weeks 9 months
Moderate to Advanced Parkinson's Disease Carbidopa/Levodopa Continuous Subdermal infusion III Yes Sham infusion 12 months Yes
Dyskinesias in Parkinson's Disease Novel oral agent II Yes 33% 1 year No

Response Form

If you or a loved one is interested in participating in one of our trials, please contact us at (855) 829-8899 or use the form below. One of our skilled Clinical Research Coordinators will contact you as soon as possible. Thank you for your interest in our research!

- Stephen S. Flitman, MD, Medical Director

Your Name
Name of Patient
Email Address
Your Telephone
Best Time to Call
Comments
 Ready?